ARTICLE | Company News
PheneX buys Lion bioscience discovery assets
November 13, 2003 8:00 AM UTC
Nuclear receptor specialist PheneX (Heidelberg, Germany) acquired from Lion bioscience (FSE:LIO; LEON) the assets that made up LIO's iD3 nuclear receptor drug discovery unit. LIO discontinued its iD3 ...